Tata Memorial Centre Evidence Based Use of Nuclear medicine diagnostic and treatment modalities in cancer-Reference-Cited by-同舟云学术

Tata Memorial Centre Evidence Based Use of Nuclear medicine diagnostic and treatment modalities in cancer

Published:2024-01 Issue:Suppl 1 Volume:61 Page:S1-S28
ISSN:0019-509X
Container-title:Indian Journal of Cancer
language:en
Short-container-title:

Author:

Puranik Ameya D.¹,Choudhury Sayak¹,Ghosh Suchismita¹,Dev Indraja D.¹,Ramchandani Varun¹,Uppal Abhishek¹,Bhosale Vikrant¹,Palsapure Abhishek¹,Rungta Rachita¹,Pandey Rakesh¹,Khatri Shweta¹,George Gemson¹,Satamwar Yogesh¹,Maske Rahul¹,Agrawal Archi¹,Shah Sneha¹,Purandare Nilendu C.¹,Rangarajan Venkatesh¹

Affiliation:

1. Department of Nuclear Medicine and Molecular Imaging, Tata Memorial Hospital and Advanced Centre for Treatment, Research and Education in Cancer (ACTREC), Homi Bhabha National Institute, Mumbai, Maharashtra, India

Abstract

Abstract PET/CT and radioisotope therapy are diagnostic and therapeutic arms of Nuclear Medicine, respectively. With the emergence of better technology, PET/CT has become an accessible modality. Diagnostic tracers exploring disease-specific targets has led the clinicians to look beyond FDG PET. Moreover, with the emergence of theranostic pairs of radiopharmaceuticals, radioisotope therapy is gradually making it’s way into treatment algorithm of common cancers in India. We therefore would like to discuss in detail the updates in PET/CT imaging and radionuclide therapy and generate a consensus-driven evidence based document which would guide the practitioners of Oncology.

Publisher

Medknow

Reference262 articles.

1. Multicenter trial of [18F] fluorodeoxyglucose positron emission tomography/computed tomography staging of head and neck cancer and negative predictive value and surgical impact in the N0 neck:Results From ACRIN 6685;Lowe;J Clin Oncol,2019

2. Accuracy of 18-F fluorodeoxyglucose positron emission tomographic/computed tomographic imaging in primary staging of squamous cell carcinoma of the oral cavity;Linz;JAMA Netw Open,2021

3. Diagnostic accuracy of F-18 FDG PET or PET/CT for detection of lymph node metastasis in clinically node negative head and neck cancer patients;A systematic review and meta-analysis;Kim;Am J Otolaryngol,2019

4. Distant metastases in head and neck cancer;Duprez;Head Neck,2017

5. Screening for distant metastases in patients with head and neck cancer;de Bree;Laryngoscope,2000